AHR and urinary bladder carcinoma: Overall, these results suggest that AhR may serve as a biomarker for poor prognosis in bladder cancer, and that 3‐IAA may modulate AhR signaling by directly binding to the receptor, thereby regulating cellular transcriptional activity and physiological responses.